The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors
Open accessAbstract
BACKGROUND: Breast cancer (BC) disparities may widen with genomic advances. The authors compared non‐Hispanic white (NHW), black, and Hispanic BC survivors for 1) cancer risk‐management practices among BRCA carriers and 2) provider discussion and receipt of genetic testing. METHODS: A population‐based sample of NHW, black, and Hispanic women who had been diagnosed with invasive BC at age 50 years or younger from 2009 to 2012 were recruited through the state cancer registry. Multiple logistic regression was used to compare cancer risk‐management practices in BRCA carriers and associations of demographic and clinical variables with provider discussion and receipt of testing. RESULTS: Of 1622 participants, 159 of 440 (36.1%) black women, 579 of 897 (64.5%) NHW women, 58 of 117 (49.6%) Spanish‐speaking Hispanic women, and 116 of 168 (69%) English‐speaking Hispanic women underwent BRCA testing, of whom 90 had a pathogenic BRCA mutation identified. Among BRCA carriers, the rates of risk‐reducing mastectomy and risk‐reducing salpingo‐oophorectomy were significantly lower among black women compared with Hispanic and NHW women after controlling for clinical and demographic variables (P = .025 and P = .008, respectively). Compared with NHW women, discussion of genetic testing with a provider was 16 times less likely among black women (P < .0001) and nearly 2 times less likely among Spanish‐speaking Hispanic women (P = .04) after controlling for clinical and sociodemographic factors. CONCLUSIONS: The current results suggest that the rates of risk‐reducing salpingo‐oophorectomy are lower among black BRCA carriers compared with their Hispanic and NHW counterparts, which is concerning because benefits from genetic testing arise from cancer risk‐management practice options. Furthermore, lower BRCA testing rates among blacks may partially be because of a lower likelihood of provider discussion. Future studies are needed to improve cancer risk identification and management practices across all populations to prevent the widening of disparities. Cancer 2017;123:2497–05. © 2017 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Self-citationAntoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
The National Comprehensive Cancer Network (NCCN).
Wood, E. H. (2004) · Journal of the Medical Library Association JMLA · Cited by 2,845
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Frank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Finch, A. P. M., Lubinski, J., Møller, P., Singer, C. F., Karlan, B., Senter, L., Rosen, B., Maehle, L., Ghadirian, P., Cybulski, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.2820 · Cited by 664
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
Armstrong, K. (2005) · JAMA · doi:10.1001/jama.293.14.1729 · Cited by 432
Hall, M. J., Reid, J. E., Burbidge, L. A., Pruss, D., Deffenbaugh, A. M., Frye, C., Wenstrup, R. J., Ward, B. E., Scholl, T. A., & Noll, W. W. (2009) · Cancer · doi:10.1002/cncr.24200 · Cited by 365
Metcalfe, K. A., Birenbaum‐Carmeli, D., Lubinski, J., Gronwald, J., Lynch, H., Moller, P., Ghadirian, P., Foulkes, W. D., Klijn, J., Friedman, E., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23340 · Cited by 342
Nelson, H. D., Pappas, M., Zakher, B., Mitchell, J. P., Okinaka-Hu, L., & Fu, R. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1684 · Cited by 319
Contralateral Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Graeser, M. K., Engel, C., Rhiem, K., Gadzicki, D., Bick, U., Kast, K., Froster, U. G., Schlehe, B., Bechtold, A., Arnold, N., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9430 · Cited by 314
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., Farmer, M., Friedman, S., Garber, J. E., Khan, S., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0018 · Cited by 292
Self-citationLevy, D. E., Byfield, S. D., Comstock, C. B., Garber, J. E., Syngal, S., Crown, W. H., & Shields, A. E. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182091ba4 · Cited by 242
Malone, K. E., Begg, C. B., Haile, R. W., Borg, A., Concannon, P., Tellhed, L., Xue, S., Teraoka, S., Bernstein, L., Capanu, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2495 · Cited by 191
McCarthy, A. M., Bristol, M., Domchek, S. M., Groeneveld, P. W., Kim, Y., Motanya, U. N., Shea, J. A., & Armstrong, K. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.66.0019 · Cited by 182
Metcalfe, K. A., Lubinski, J., Ghadirian, P., Lynch, H., Kim-Sing, C., Friedman, E., Foulkes, W. D., Domchek, S., Ainsworth, P., Isaacs, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.6078 · Cited by 176
Disparities in Genetic Testing: Thinking Outside the BRCA Box
Hall, M. J., & Olopade, O. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.5889 · Cited by 174
Prevention and Management of Hereditary Breast Cancer
Narod, S. A., & Offit, K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.035 · Cited by 169
Awareness and Utilization of BRCA1/2 Testing Among U.S. Primary Care Physicians
Bellcross, C. A., Kolor, K., Goddard, K. A. B., Coates, R. J., Reyes, M., & Khoury, M. J. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.09.027 · Cited by 166
Wood, M. E., Kadlubek, P., Pham, T. H., Wollins, D. S., Lu, K. H., Weitzel, J. N., Neuss, M. N., & Hughes, K. S. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.4661 · Cited by 166
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer
Rosenberg, S. M., Ruddy, K. J., Tamimi, R. M., Gelber, S. I., Schapira, L., Come, S. E., Borges, V. F., Larsen, B. G., Garber, J. E., & Partridge, A. H. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5941 · Cited by 159
Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance
Schwartz, M. D., Isaacs, C. J., Graves, K. D., Poggi, E. A., Peshkin, B. N., Gell, C., Finch, C., Kelly, S. P., Taylor, K. L., & Perley, L. E. (2011) · Cancer · doi:10.1002/cncr.26294 · Cited by 147
Drohan, B., Roche, C. A., Cusack, J. C., & Hughes, K. S. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2257-y · Cited by 128
Risk management options elected by women after testing positive for a BRCA mutation
Garcia, C., Wendt, J. M., Lyon, L. L., Jones, J. E., Littell, R. D., Armstrong, M. A., Raine‐Bennett, T. R., & Powell, C. B. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.12.014 · Cited by 115
Racial and Ethnic Disparities in Awareness of Genetic Testing for Cancer Risk
Pagán, J. A., Su, D., Li, L., Armstrong, K., & Asch, D. A. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.07.021 · Cited by 109
Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome
Roukos, D. H., & Briasoulis, E. C. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0930 · Cited by 107
Jagsi, R., Griffith, K. A., Kurian, A. W., Morrow, M., Hamilton, A. S., Graff, J. J., Katz, S. J., & Hawley, S. T. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.5885 · Cited by 105
Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers
Beattie, M. S., Crawford, B., Lin, F., Vittinghoff, E., & Ziegler, J. L. (2009) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2008.0067 · Cited by 99
Barriers and facilitators to BRCA genetic counseling among at‐risk Latinas in New York City
Sussner, K. M., Jandorf, L. H., Thompson, H. S., & Valdimarsdottir, H. B. (2012) · Psycho-Oncology · doi:10.1002/pon.3187 · Cited by 77
BRCA Genetic Counseling Among At‐Risk Latinas in New York City: New Beliefs Shape New Generation
Sussner, K. M., Edwards, T. A., Villagra, C., Rodriguez, M. C., Thompson, H. S., Jandorf, L. H., & Valdimarsdottir, H. B. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9746-z · Cited by 61
Prince, A. E. R. (2015) · Journal of Law and the Biosciences · doi:10.1093/jlb/lsv008 · Cited by 58
Interest and Beliefs About BRCA Genetic Counseling Among At‐Risk Latinas in New York City
Sussner, K. M., Jandorf, L. H., Thompson, H. S., & Valdimarsdottir, H. B. (2010) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9282-4 · Cited by 57
Gammon, A., Rothwell, E., Simmons, R. G., Lowery, J. T., Ballinger, L., Hill, D. A., Boucher, K. M., & Kinney, A. Y. (2011) · Journal of Genetic Counseling · doi:10.1007/s10897-011-9376-7 · Cited by 56
Adherence to Recommended Risk Management among Unaffected Women with a BRCA Mutation
Buchanan, A. H., Voils, C. I., Schildkraut, J. M., Fine, C. A., Horick, N., Marcom, P. K., Wiggins, K., & Skinner, C. S. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-9981-6 · Cited by 51
Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors
Jones, T., Lockhart, J. S., Mendelsohn‐Victor, K., Duquette, D. A., Northouse, L., Duffy, S. A., Donley, R., Merajver, S. D., Milliron, K. J., Roberts, J. S., et al. (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.03.016 · Cited by 50
Pal, T., & Vadaparampil, S. T. (2012) · Cancer Control · doi:10.1177/107327481201900402 · Cited by 49
Self-citationKinney, A. Y., Simonsen, S. E., Baty, B. J., Mandal, D. M., Neuhausen, S. L., Seggar, K., Holubkov, R., Bloor, L. E., & Smith, K. R. (2006) · Journal of Genetic Counseling · doi:10.1007/s10897-006-9026-7 · Cited by 48
Disparities in cancer care among racial and ethnic minorities.
Kolb, B., Wallace, A. M., Hill, D., & Royce, M. (2006) · PubMed · Cited by 41
Cited by
Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps
Polygenic Risk Score Task Force of the International Common Disease Alliance, Adeyemo, A., Balaconis, M. K., Darnes, D. R., Fatumo, S., Granados Moreno, P., Hodonsky, C. J., Inouye, M., Kanai, M., Kato, K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01549-6 · Cited by 413
An Overview of PARP Inhibitors for the Treatment of Breast Cancer
Cortesi, L., Rugo, H. S., & Jackisch, C. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00796-4 · Cited by 393
Landry, L. G., Ali, N., Williams, D. R., Rehm, H. L., & Bonham, V. L. (2018) · Health Affairs · doi:10.1377/hlthaff.2017.1595 · Cited by 344
Mittendorf, K. F., Knerr, S., Kauffman, T. L., Lindberg, N. M., Anderson, K. P., Feigelson, H. S., Gilmore, M. J., Hunter, J. E., Joseph, G., Kraft, S. A., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00233 · Cited by 42
Metadata
- Authors
- Cragun, D., Weidner, A., Lewis, C., Bonner, D., Kim, J., Vadaparampil, S. T., & Pal, T.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2017-02-09
- Volume
- 123
- Issue
- 13
- Pages
- 2497-2505
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2587623479
- Cited by
- 293
- References
- 43
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.